ArticleWorld journal of urology2010

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer.

Christoph W M Reuter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.